Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of CoronaVac in Healthy Adults
NCT04352608Phase 2Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Apr 2020
- Primary completion
- Jul 2020
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of coronavac in coronavirus disease 2019 (COVID-19), sponsored by Sinovac Biotech Ltd.. Started Apr 2020; status: completed.
02
Drugs
coronavac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04352608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04352608.